Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data.
暂无分享,去创建一个
[1] J. Fawcett,et al. Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program. , 1987, Psychopharmacology bulletin.
[2] Anthony S. Bryk,et al. Application of Hierarchical Linear Models to Assessing Change , 1987 .
[3] D. Hedeker,et al. Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data. , 1988, Psychopharmacology bulletin.
[4] K. Howard,et al. Attrition in substance abuse comparative treatment research: the illusion of randomization. , 1990, NIDA research monograph.
[5] Joyce A. Cramer,et al. Patient Compliance in Medical Practice and Clinical Trials , 1991 .
[6] J H Ellenberg,et al. Analysis of clinical trials by treatment actually received: is it really an option? , 1991, Statistics in medicine.
[7] M. Schuckit,et al. The anatomy of a follow-up. , 1992, British journal of addiction.
[8] P W Lavori,et al. Clinical trials in psychiatry: should protocol deviation censor patient data? , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[9] S D Imber,et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. , 1993, Archives of general psychiatry.
[10] R. J. Hayes,et al. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology , 1996, BMJ.
[11] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[12] F. D. Del Boca,et al. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. , 1996, Alcoholism, clinical and experimental research.
[13] W. Compton,et al. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. , 1996, Drug and alcohol dependence.
[14] A. Edwards,et al. Outcome studies of brief alcohol intervention in general practice: the problem of lost subjects. , 1997, Addiction.
[15] F. D. Del Boca,et al. Compliance with treatment and follow-up protocols in project MATCH: predictors and relationship to outcome. , 1998, Alcoholism, clinical and experimental research.
[16] K. Carroll,et al. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. , 1998, Addiction.
[17] B. Crawley,et al. Reporting of randomized clinical trial descriptors and use of structured abstracts. , 1998, JAMA.
[18] C. Meinert. Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials. , 1998, JAMA.
[19] P. Lavori,et al. Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today. NIDA/VA/SU Working Group on Design and Analysis. , 1999, Journal of clinical psychopharmacology.
[20] S. Hollis,et al. What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.
[21] B. Kupelnick,et al. Effectiveness of antidepressants , 1999, British Journal of Psychiatry.
[22] M. Martínez-González,et al. Intention to treat analysis is related to methodological quality , 2000, BMJ : British Medical Journal.
[23] B. Rounsaville,et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. , 2000, Drug and alcohol dependence.
[24] Patrick E. McKnight,et al. Multivariate modeling of missing data within and across assessment waves. , 2000, Addiction.
[25] H. Williams,et al. How well are randomized controlled trials reported in the dermatology literature? , 2000, Archives of dermatology.
[26] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.
[27] Alvan R. Feinstein,et al. Principles of Medical Statistics , 2001 .
[28] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[29] A. Blaszczynski,et al. Dropouts in clinical research: Do results reported reflect clinical reality? , 2001 .
[30] D Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.
[31] Paul D. Bliese,et al. Book Review: Modeling Longitudinal and Multilevel Data: Practical Issues, Applied Approaches, and Specific Examples, edited by T. D. Little, K. U. Schnabel, and J. Baumert (2000). Mahwah, Nj: Lawrence Erlbaum. , 2003 .